Role of pharmacogenetics in busulfan/cyclophosphamide conditioning therapy prior to hematopoietic stem cell transplantation

Author： Hassan Moustapha   Andersson Borje S  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.14, Iss.1, 2013-01, pp. : 75-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacogenetic Aspects of Drug Metabolizing Enzymes in Busulfan Based Conditioning Prior to Allogenic Hematopoietic Stem Cell Transplantation in Children

By  

Current Drug Metabolism, Vol. 15, Iss. 3, 2014-03 ,pp. : 251-264

Bentham Science Publishers

Access to resources Recommend Favorite

Intravenous Busulfan: In the Conditioning Treatment of Pediatric Patients Prior to Hematopoietic Stem Cell Transplantation

By Hoy Sheridan M.   Lyseng-Williamson Katherine A.  

Pediatric Drugs, Vol. 9, Iss. 4, 2007-01 ,pp. : 271-278

Adis International

Access to resources Recommend Favorite

High-dose treosulfan in conditioning prior to hematopoietic stem cell transplantation

By Główka Franciszek K   Romański Michał   Wachowiak Jacek  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 10, 2010-10 ,pp. : 1275-1295

Informa Healthcare

Access to resources Recommend Favorite

Can the pharmacogenetics of GST gene polymorphisms predict the dose of busulfan in pediatric hematopoietic stem cell transplantation?

By Ansari Marc   Krajinovic Maja  

Pharmacogenomics, Vol. 10, Iss. 11, 2009-11 ,pp. : 1729-1732

Future Medicine

Access to resources Recommend Favorite

Busulfan/cyclophosphamide: Mesenteric inflammatory veno-occlusive disease in a stem cell transplant recipient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1205, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite